Items where Author is "Forcade, Edouard"
 | Up a level |
Conference or Workshop Item
Barbullushi, Kordelia and Labopin, Myriam and Kroeger, Nicolaus and Finke, Juergen and Stelljes, Matthias and Ganser, Arnold and Bethge, Wolfgang and Einsele, Herman and Schetelig, Johannes and Fanin, Renato and Jindra, Pavel and Schroeder, Thomas and Casper, Jochen and Edinger, Matthias and Passweg, Jakob and Forcade, Edouard and Tischer, Johanna and Nagler, Arnon and Ciceri, Fabio and Mohty, Mohamad (2023) OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM DIFFERENT DONOR TYPES IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA: A REPORT FROM THE ALWP OF THE EBMT. In: 49th Annual Annual Meeting of the European Society for Blood and Marrow Transplantation, 23 - 26 April, 2023, Hybrid Meeting.
Barbullushi, Kordelia and Labopin, Myriam and Kroeger, Nicolaus and Finke, Juergen and Stelljes, Matthias and Ganser, Arnold and Bethge, Wolfgang and Einsele, Hermann and Schetelig, Johannes and Fanin, Renato and Jindra, Pavel and Casper, Jochen and Schroeder, Thomas and Edinger, Matthias and Passweg, Jakob and Forcade, Edouard and Tischer, Johanna and Nagler, Arnon and Ciceri, Fabio and Mohty, Mohamad (2022) Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT. In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.
Other
Heim, Dominik and Passweg, Jakob and Medinger, Michael and Schanz, Urs and Finke, Juergen and Stomper, Julia and Holler, Ernst and Schmid, Julia and Hilgendorf, Inken and Winkelmann, Nils and Holtick, Udo and Scheid, Christoph and Socie, Gerard and Robin, Marie and Milpied, Noel-Jean and Forcade, Edouard and Yakoub-Agha, Ibrahim and Magro, Leonardo and Jarvis, Philip and Jones, Julie and Sanchez, David and Mahajan, Navon and Souquieres, Malika and Bucher, Christoph and Gergely, Peter (2019) GVHD prophylaxis with KRP203, a sphingosine-1-phosphate receptor modulator, is safe and may have the potential to improve survival in patients undergoing allogeneic stem cell transplantation. NATURE PUBLISHING GROUP, LONDON.
